Ad News Live
UnitedHealth Earnings: UnitedHealth Group reported first-quarter earnings on Tuesday that exceeded Wall Street expectations.
The company also increased its profit forecast for 2026, citing improved control over medical costs and ongoing operational efficiencies.
The insurer now expects adjusted earnings for 2026 to surpass $18.25 per share.
This marks an increase from its prior projection of more than $17.75 per share. UnitedHealth reaffirmed its full-year revenue guidance of over $439 billion.
The company said the outlook reflects continued efforts to optimize operations and align resources across its business segments.
UnitedHealth Group reported first-quarter results that surpassed Wall Street forecasts, according to analyst estimates compiled by LSEG.
The company posted adjusted earnings of $7.23 per share. This exceeded expectations of $6.57 per share.
Revenue reached $111.72 billion for the quarter. Analysts had projected revenue of $109.57 billion.
UnitedHealth is now relying on a revamped leadership team to execute a broader turnaround plan.
The strategy includes reducing membership levels and divesting the U.K. operations of its Optum division.
The company is also increasing investments in artificial intelligence. It aims to simplify patient access to care and improve transparency across its services.
These measures are intended to restore profitability and rebuild the company’s reputation following operational challenges over the past two years.
UnitedHealth Group reported first-quarter net income of $6.28 billion. Earnings came in at $6.90 per share. The figures were nearly unchanged from a year earlier.
In the same quarter last year, the company recorded $6.29 billion in profit, or $6.85 per share. On an adjusted basis, results were stronger.
Excluding factors such as divestitures, restructuring charges, and planned reserve reductions tied to underperforming contracts, earnings reached $7.23 per share.
Revenue increased to $111.72 billion during the quarter. This marked an improvement from $109.58 billion in the prior-year period.
Both the company’s insurance arm, UnitedHealthcare, and its healthcare services unit, Optum, delivered sales above analyst expectations, according to StreetAccount.
UnitedHealth Group is showing improved control over rising medical expenses. The issue has weighed on the broader insurance sector for more than two years.
Health insurers have faced sustained cost pressure. This has been driven in part by patients returning for care they postponed during the COVID-19 pandemic.
Companies offering privately managed Medicare Advantage plans have been particularly affected.
A surge in utilization has increased overall spending. Higher costs have also been linked to expensive specialty treatments.
These include widely used GLP-1 drugs, which have gained traction for diabetes and weight management.
The combination of delayed care demand and rising drug expenses has continued to challenge insurers across the industry.
UnitedHealth Group reported a medical benefit ratio of 83.9% for the first quarter. This metric tracks how much the company spends on medical care compared with the premiums it collects.
The ratio declined from 84.8% in the same quarter last year. A lower figure typically reflects improved margins, as less of each premium dollar is used to cover healthcare costs.
The result also outperformed analyst expectations. Wall Street had projected a ratio of 85.5% for the period, according to StreetAccount.
UnitedHealth Group said its first-quarter medical cost performance reflects tighter expense management and the release of reserves tied to underperforming Optum contracts.
The company noted that these gains were partly offset by persistently high healthcare costs across the system.
Chief Executive Officer Stephen Hemsley said the company remains focused on improving the healthcare experience.
He stated that efforts are underway to simplify services and modernize care delivery.
He added that the company aims to enhance value, affordability, transparency, and connectivity for patients and providers.
The earnings update follows a recent policy development in Washington.
The Trump administration finalized a higher-than-expected payment rate increase for 2027 under Medicare Advantage.
The decision is seen as supportive for UnitedHealth and other major health insurers.
Follow Us
